Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
2-amino-3-(4-amino-1H-indol-3-yl)propanoic acid
- Development stage
- Unknown
- Modality
- Small Molecules
01
Overview
2-amino-3-(4-amino-1H-indol-3-yl)propanoic acid is a synthetic small molecule belonging to the class of indolyl carboxylic acids and derivatives. It is structurally related to tryptophan, with an amino group at the 4-position of the indole ring. The compound has been studied as an experimental agent but has not been approved for any therapeutic use or entered clinical development beyond preclinical or early research phases. Its mechanism of action, pharmacological effects, and potential indications are not established in humans[2][4]. There are no known brand names or marketed formulations.
- Other names
- 2-amino-3-(4-aminoindol-3-yl)propanoic acid
Beyond the preview
Go deeper on 2-amino-3-(4-amino-1H-indol-3-yl)propanoic acid.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 2-amino-3-(4-amino-1H-indol-3-yl)propanoic acid.